Bausch Health Co. Inc. (BHC) Announces D. Robert Hale Has Resigned From Its Board Of Directors
Get Alerts BHC Hot Sheet
Join SI Premium – FREE
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced that D. Robert Hale has resigned from his role as an independent director of the Company's Board of Directors ("Board") to focus on other business obligations related to his firm, ValueAct Capital ("ValueAct"), a shareholder of the Company.
"Rob has been a valued member of our Board since 2015, including formerly serving as our Chair of the Finance and Transactions Committee and as a member of the Talent and Compensation Committee, and most recently serving on the Special Transaction Committee. I would like to express my gratitude to ValueAct and to Rob for his numerous contributions, particularly as we have continued to transform Bausch Health," said Joseph C. Papa, chairman and CEO, Bausch Health. "As we continue to work to execute the spinoff of Bausch + Lomb and create two attractive businesses to unlock value, we are focused on forming two strong Boards with diverse representation and perspectives to ensure we represent the customers, patients and shareholders we serve around the world."
The Company and entire Board would like to thank Mr. Hale for his services and contributions and wish him well in his future endeavors.
"It has been a privilege to serve on the Bausch Health Board under Joe's leadership as he and the executive team transformed the Company in line with a mission to improve people's lives with the Company's health care products. With my increasing professional responsibilities outside of Bausch Health, including joining the board of a second company headquartered in Japan last week, and considering my capable colleagues on the Board representing all of Bausch Health's shareholders, I am resigning my seat," said D. Robert Hale.
"I fully support the Company's strategy to separate the global eye health business, its efforts to accelerate this strategy, and the ongoing leadership selection process. ValueAct remains an engaged and supportive shareholder. We are excited for what's ahead," Mr. Hale continued.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Visa (V) stock rises as Q2 earnings, revenue come ahead of estimates
- Volato (SOAR) Announces Board Changes
- Renasant Corp. (RNST) Appoints Kevin D. Chapman as Next CEO
Create E-mail Alert Related Categories
Board Changes, Corporate NewsRelated Entities
ValueAct Capital, LLC, Jeffrey W. Ubben, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!